TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) Investor Investigation Over Potential Securities Laws Violations Announced

  • If you purchased shares of GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this investigation, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Investigation Overview

Company
GW Pharmaceuticals PLC
Security
NASDAQ: GWPH

Summary

January 11, 2016 (Shareholders Foundation) - An investigation on behalf of investors of GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) shares over potential securities laws violations by GW Pharmaceuticals and certain of its directors and officers in connection certain financial statements was announced.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) concerning whether a series of statements by GW Pharmaceuticals regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

GW Pharmaceuticals PLC- ADR reported that its Total Revenue declined from GBP 30.05 million for the 12 months period that ended on September 30, 2014 to GBP 28.54 million for the 12 months period that ended on September 30, 2015 and that its Net Loss for those respective time periods increased from GBP 14.66 million to GBP 44.56 million.

Shares of GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) declined from as high as $129.69 per share in June 2015 to as low as $52.92 per share on January 11, 2016.

Start Monitoring Your Investments